Insight July 2025 The Purple Tariff Turbulence: How Trade Wars Reshaped Securities Lending in H1 2025 The securities lending market thrives on market volatility and since Trump took office the VIX volatility index peaked to levels not seen since March 2020, when COVID rattled the globe. According to President Trump, “Tariffs is the most beautiful […]
Insight July 2025 The Purple H1 2025: Securities Lending Market Revenue EquiLend looks back on the drivers of lending revenue in the first half of 2025 in the 19th Edition of EquiLend The Purple. As we arrive at the midway point of 2025, trade and market volatility remain the global topics of conversation. The Trump […]
EquiLend’s Head of Trading Solutions, Mike Norwood, shares his global monthly market review for securities finance with insight on EMEA from Rowena Brown, Head of Trading Solutions EMEA & APAC and Andy McCardle, Head of EquiLend APAC.
EquiLend Data & Analytics surfaced elevated short interest in NOVA, averaging 28.8%, well before the June 9 bankruptcy filing.
This Hong Kong-listed pharmaceutical stock climbed 30% in 3 weeks — yet short positioning rose sharply: borrow quantity increased 182% and utilization more than doubled.
The global securities finance industry generated $955 million in revenue for lenders in May 2025, according to EquiLend Data & Analytics – a 7% increase from $895 million in May 2024.
In the wake of President Trump’s announcement of prescription price reform, the S&P 500 Pharmaceutical Industry Index fell more than 5% over the following 3 days trailing the broader index by nearly 9% over that span.
UnitedHealth Group (TICKER: UNH) shares fell from $600 on April 11 to $275 as of May 15 erasing over $300 billion in market value as rising medical costs, regulatory pressures and a Department of Justice criminal investigation into possible Medicare fraud undermined investor confidence.
In the ever-evolving landscape of securities finance, the introduction of T+1 settlement has proven to be a flash point for the industry.
EquiLend Data & Analytics identifies NetClass Technology as a prime short squeeze candidate, with its short squeeze score at 90.
EquiLend’s Head of Trading Solutions, Mike Norwood, shares his global monthly market review for securities finance with insight on EMEA from Rowena Brown, Head of Trading Solutions EMEA & APAC and Andy McCardle, Head of EquiLend APAC.
EquiLend Data & Analytics identifies Regencell Bioscience as a prime short squeeze candidate, with its short squeeze score at 88.
Nick Delikaris lays out his vision for securities finance powered by advancing technology – it looks like real savings, tangible impact & flexible adoption
The global securities finance industry generated $856 million in revenue for lenders in April 2025, according to EquiLend Data & Analytics. The figure represents a 1.18% increase from the $846 million generated in April 2024.
The first quarter of 2025 was a period of heightened volatility and uncertainty for global markets, driven by a confluence of macroeconomic and geo-political factors.
Navigating short interest in the corporate bond market can be filled with risk. The lack of transparency and public reporting forces investors to use limited tools while today’s macroeconomic volatility provides prime conditions for short selling.
In Q1 2025, the lending of APAC equities bolstered revenue for the rest of the securities finance market by reporting a 29% increase in year-over-year revenue of $569 million.
EquiLend Data & Analytics identifies Janover Inc as a prime short squeeze candidate, as the EquiLend Short Squeeze Score surged to 86 indicating extreme potential for continued short covering.
An analysis of the recommendations, challenges and opportunities of automating SSIs, from the FMSB Core Principles, and recommendations from the UK Accelerated Settlement Taskforce.
Dimitri Arlando gives his opinion on how Saudi Arabia is redefining securities lending in emerging markets in this article in Securities Finance Times.
EquiLend Short Squeeze Score | Designed to provide early warning signals of potential short squeezes, using both comprehensive securities finance data and social media sentiment data.
EquiLend Data & Analytics identifies Summit Therapeutics as a prime short squeeze candidate, with its squeeze score surging 43.0 points to 66 in just one month. With utilization approaching 78.98% and elevated borrow fees, short sellers are facing mounting pressure as positive clinical trial results drive momentum.
EquiLend, the global leader in data and technology for the securities finance industry, has announced the launch of its Short Squeeze Score – a unique trading signal designed to provide an early warning of potential short squeezes.
EquiLend’s Head of Trading Solutions, Mike Norwood, shares his global monthly market review for securities finance with insight on EMEA from Rowena Brown, Head of Trading Solutions EMEA & APAC and Andy McCardle, Head of EquiLend APAC.
EquiLend Orbisa | Short-interest corporate bond data in real-time. Access market signals in security-level liquidity, financing cost and approximate short interest to proactively navigate the global credit markets.
Lender-to-borrower securities lending revenue totaled $2.29 billion in Q1 2025, marking a 2% increase year-over-year, according to newly released data from EquiLend’s DataLend platform.
Rich Grossi reviews his new role as EquiLend CEO and how he will take the company forward.
EquiLend’s Head of Trading Solutions, Mike Norwood, shares his global monthly market review for securities finance with insight on EMEA from Rowena Brown, Head of Trading Solutions EMEA & APAC and Andy McCardle, Head of EquiLend APAC.
EquiLend, the global leader in technology, data and analytics solutions for the securities finance industry, today announced the appointment of Nick Delikaris as Chief Product Officer and a member of the company’s Executive Leadership Team.
EquiLend, the global leader in technology, data and analytics solutions for the securities finance industry, today announced a minority investment from an affiliate of The Bank of New York Mellon Corporation (BNY) (NYSE: BK).
The global securities finance industry generated $703 million in revenue for lenders in February 2025, according to DataLend, the market data service of fintech EquiLend.
DataLend highlights the latest trends in securities finance for the Canada region.
On February 12, 2025, FINRA published an updated SLATE (Securities Lending Aggregated Transaction Engine) draft v1.1, a critical step in the ongoing implementation of SEC Rule 10c-1a.
EquiLend’s Head of Trading Solutions, Mike Norwood, shares his global monthly market review for securities finance with insight on EMEA from Rowena Brown, Head of Trading Solutions EMEA & APAC and Andy McCardle, Head of EquiLend APAC.
The global securities finance industry generated $773 million in revenue for lenders in January 2025, according to DataLend, the market data service of fintech EquiLend.
After aggressively hiking interest rates to a 10-year high of 5.5%, the U.S. Federal Reserve started 2024 in a holding-pattern of sorts. Inflation measures were cooling, but the American consumer was still feeling the pain of high prices.
With two months now elapsed since the 2024 U.S. presidential election, policy shifts planned by the incoming administration have begun to come into focus, and broader financial markets have reacted in kind. While the implications of a potentially dramatic shift are only beginning to be realized, there are key signals and themes which can already be observed within the securities finance market.
As U.S. equity markets rallied in 2024, securities lending revenue for U.S. equities faced significant challenges, with Q4 revenue down 7% year-over-year (YoY), contributing to a total annual decline of 17%. A 22% drop in fees drove the decrease and offset a 5% increase in balances, which was driven by increased valuations.
While global securities lending revenue faced headwinds in 2024, the Asia-Pacific (APAC) region showed resilience, experiencing a comparatively modest 1.8% year-over-year (YoY) decline to $2.1 billion. The majority of revenue was generated by equities, contributing $2 billion, representing a 0.3% YoY decline. A 3.3% increase in fees was offset by a 3.8% decrease in on-loan balances.
EquiLend’s 2024 in Review Trading infographic offers a holistic view of 2024 covering multiple asset classes, regions, sectors, global trends and more from the lens of EquiLend NGT.
EquiLend’s Head of Trading Solutions, Mike Norwood, shares his global monthly market review for securities finance with insight on EMEA from Rowena Brown, Head of Trading Solutions EMEA & APAC and Andy McCardle, Head of EquiLend APAC.